GWPH - GW Pharmaceuticals

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, May 5, 2016.

Tags:
  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    [​IMG]
    GW Pharmaceuticals (GWPH) is a British biopharmaceutical company known for its multiple sclerosis treatment product Sativex, nabiximols (brand name, Sativex). Sativex is the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, for treatment of epilepsy, underwent phase 3 clinical trials in 2015.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    Reported before open today (5/5/16)
    Earnings: EPS -$0.09 Revenue $3.81M
    Estimates: EPS -$1.57 Revenue $5.99M

    Down 2.93% in pre-market
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Watching for a move above $100
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Looks like Fridays sell off was a mistake that sellers are regretting.

    Buyers piling back in big time!
     
  5. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Whoa! Look at that thing run!
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    And more!

    I should have jumped in earlier this month dammit!!!
     
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Some upside action today off the Sept support right before it gapped higher.
     
  8. LloydWCoutee

    LloydWCoutee Active Member

    Joined:
    May 4, 2016
    Messages:
    721
    Likes Received:
    58
    Should've kept it all the entire run. Oh well. Potential top rev inbound.
     
  9. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
  10. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Buyers still in control here!
     
  11. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    I like this action today, but I think it is going to need a lot more volume to get over that $130 resistance:

    [​IMG]
     
    T0rm3nted likes this.
  12. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,448
    Likes Received:
    3,268
    The reason for the bump today was mainly an earnings beat.

    upload_2016-12-5_21-11-17.png
     
  13. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    702
    Likes Received:
    63
  14. Gambit

    Gambit Active Member

    Joined:
    Oct 16, 2016
    Messages:
    702
    Likes Received:
    63
    The problem for shareholders is that the company seemingly has run out of positive catalysts for the time being. GWPH’s Epidiolex story is right on track. However, the company will submit the new drug application (NDA) for Epidiolex in the first half of 2017 … and after that submission, GWPH shareholders might have to wait until the end of 2017 for the next piece of good news.
    Without a reason to buy, investors and traders might take some of their profits off the table, especially in the first few months of the year.
     
  15. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    4,319
    Likes Received:
    3,375
    Let's see if this can hold above the 20 sma.
    I'm seeing on finviz only 2.25M shares in the float(!), and only 30M shares total outstanding.
     

Share This Page